PREVENT: Preeclampsia Detection – Verifying a Novel Rapid Test featuring MOMM Diagnostics
Mathias Wipf of MOMM Diagnostics GmbH will improve their préXclude test to better enable its use in low- and middle-income countries (LMICs) as an affordable point-of-care diagnostic platform for prediction and detection of preeclampsia early in pregnancy. Read More
mOm Incubators Receives FDA Clearance for First-of-Its-Kind Portable Incubator for Premature Babies
Unique, easy-to-use, lightweight incubator enables care anywhere and everywhere while avoiding separation of mother and baby Potential for novel incubator to address key aspects of preterm neonatal care and reduce dependence on NICU NOTTINGHAM, England–(BUSINESS WIRE)–mOm Incubators Limited announced today... Read More →
Abbott and AtaCor Medical Collaborate on Advanced Extravascular ICD Technology
Collaboration pairs AtaCor’s investigational extravascular ICD lead with Abbott’s investigational extravascular ICD system to deliver potentially life-saving therapies AtaCor plans to initiate a pivotal Investigational Device Exemption (IDE) clinical trial in 2026 to evaluate the investigational extravascular implantable cardioverter defibrillator... Read More →
Press Release Nanochon closes $4.1M Seed Prime II Funding Round
WASHINGTON, January 12, 2026 — Nanochon, a Washington, DC-based orthopedic device company developing an implant for treating articular cartilage defects in the knee, has secured commitments to close an oversubscribed funding round, bringing its total capital raised to date to... Read More →
Avenue Biosciences raises $5.7M to scale the first platform modulating the secretory pathway for enhanced therapeutic protein manufacturing
– Funding will be used to scale the first technology for measuring and modulating the efficacy of the protein secretory pathway, a critical bottleneck affecting the development and manufacturing of therapeutic proteins. – The Avenue technology generates thousands of versions... Read More →
GelSana Hires Chief Commercial Officer
Medtech Industry Veteran joins GelSana as Chief Commercial Officer (AURORA, CO) – January 09, 2026 – GelSana Therapeutics, Inc. (“GelSana”), a wound care company developing novel polymer-based dressings to accelerate healing, today announced that Donald Gregg has joined the company... Read More →
PharmaJet’s Needle-free Injection System Selected to Administer DNA Immunotherapy for Advanced Melanoma in Late-stage Clinical Development following Positive Phase 2 Data
PharmaJet’s intramuscular (IM) Needle-free Injection System – Stratis® – was used to deliver Scancell’s iSCIB1+ DNA immunotherapy in combination with immune checkpoint inhibitors in the SCOPE Phase 2 trial. The Scancell immunotherapy delivered using PharmaJet’s Stratis demonstrated a Progression-Free Survival... Read More →
AccurKardia Secures FDA 510(k) Clearance of and Launches AccurECG 2.0
Newly cleared AccurECG 2.0 is enterprise-grade, device-agnostic ECG interpretation platform designed for scale, accelerated turnaround, and flexible customer integrations. NEW YORK–(BUSINESS WIRE)–AccurKardia, an ECG-led diagnostics software company focused on transforming ECG data into a more powerful diagnostic tool and broad... Read More →
FineHeart secures €83 million to support its growth
Bordeaux, France – January 8, 2026 – FineHeart, a clinical-stage medical technology company specializing in the development of innovative solutions for cardiology, announced today the completion of a €35 million first closing of its Series C financing round. This funding... Read More →
Prevencio and Quadrant Health Announce Partnership to Integrate HART CVE and HART CADhs AI-Blood Tests into Primary Care
Partnership expands access to AI cardiometabolic risk insights to support earlier detection, clearer triage, and more personalized care pathways KIRKLAND, WA, UNITED STATES, January 8, 2026 /EINPresswire.com/ — Prevencio, Inc., a leader in advanced, AI-driven multiprotein-based cardiovascular and cardiometabolic risk... Read More →